Insulin regulates cell function by first binding to the insulin receptor (IR) localized on the cell surface. With the cloning of IR cDNA and the IR-gene promoter, the regulation of the IR gene during differentiation and by various hormones can be studied. Muscle is a major target tissue for insulin action. BC3H1 cells, a mouse muscle cell line in culture, are a model cell type for studying insulin action. Differentiation in these cells results in a 5- to 10-fold increase in IR binding and a 5- to 10-fold increase in IR content. Studies of IR mRNA by Northern and slot-blot analyses reveal a 10-fold increase in IR mRNA after differentiation. These studies indicate that there is a selective increase in IR-gene expression during muscle differentiation. A similar increase in IRgene expression is observed for the IR during pancreatic acinar cell differentiation. Glucocorticoids increase IR content in several target tissues. Studies in cultured IM-9 lymphocytes indicate that glucocorticoids induce a 5-fold increase in IR mRNA levels. Studies of IR mRNA half-life indicate that glucocorticoids do not alter IR mRNA stability. When the transcription of the IR is measured by elongation assays, glucocorticoids directly stimulate IR transcription 5- to 10-fold. The effect is detectable within 30 min of glucocorticoid treatment and is maximal within 2 h. Therefore, these studies demonstrate that the IR gene is under the direct regulation of glucocorticoids. Insulin downregulates the IR in various target tissues. Prior studies indicate that this downregulation was partly because of accelerated IR degradation. Studying AR42J pancreatic acinar cells, we also found that insulin accelerates IR degradation. Moreover, in these cells, insulin decreases IR biosynthesis by ∼50%. Studies of IR mRNA indicate there is a concomitant decrease in IR mRNA levels after insulin treatment. Thus, insulin decreases IR-gene expression. The genomic structure of the IR promoter has been elucidated. Primer extension and nuclease S, analysis indicate that IR mRNA has multiple start sites. The promoter fragment was ligated to a promoterless “reporter” plasmid containing the bacterial gene chloramphenicol acetyltransferase (CAT). When this plasmid is transfected into cultured cells, CAT activity is detected, indicating promoter activity. Various portions of a genomic fragment were ligated to a promoter to study glucocorticoid regulation of the IR promoter. These studies indicate that IR-gene expression is regulated by differentiation and hormonal agents. Differentiation in muscle and acinar pancreas is associated with an increase in IRmRNA. When differentiated cells are studied, glucocorticoids upregulate IR-gene expression, whereas insulin downregulates this function.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1990
Regulating Insulin-Receptor-Gene Expression by Differentiation and Hormones
P W Mamula, Phd;
P W Mamula, Phd
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
A R McDonald, PhD;
A R McDonald, PhD
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
A Brunetti, MD;
A Brunetti, MD
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
Y Okabayashi, MD, PhD;
Y Okabayashi, MD, PhD
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
K Y Wong, BS;
K Y Wong, BS
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
B A Maddux, BS;
B A Maddux, BS
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
C Logsdon, PhD;
C Logsdon, PhD
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
I D Goldfine, MD
I D Goldfine, MD
Division of Diabetes and Endocrine Research and the Department of Medicine, Mount Zion Hospital and Medical Center; and the Departments of Medicine and Physiology, University of California
San Francisco, San Francisco, California
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Ira Goldfine, Division of Diabetes and Endocrine Research and Department of Medicine, Mount Zion Hospital and Medical Center, PO Box 7921, San Francisco, CA 94120.
Citation
P W Mamula, A R McDonald, A Brunetti, Y Okabayashi, K Y Wong, B A Maddux, C Logsdon, I D Goldfine; Regulating Insulin-Receptor-Gene Expression by Differentiation and Hormones. Diabetes Care 1 March 1990; 13 (3): 288–301. https://doi.org/10.2337/diacare.13.3.288
Download citation file: